Those with mortgages are bank-hopping at record rates, but not necessarily to get lower interest rates. 

More than 3,500 holders switched nearly two and a half billion dollars of debt between loan providers last month. 

It's the highest since records began in 2017. 

Cotality Chief Property Economist Kelvin Davidson says it reflects a mix of factors including short term loans, minimal or no break fees, and cash-back incentives. 

He told Ryan Bridge it’s reasonably common to get 0.7-0.8% of the loan value as a cashback, up to certain caps, so it would make sense for people who are potentially under cashflow stress. 

LISTEN ABOVE 

Those with mortgages are bank-hopping at record rates, but not necessarily to get lower interest rates.&nbsp;
More than 3,500 holders switched nearly two and a half billion dollars of debt between loan providers last month.&nbsp;
It's the highest since records began in 2017.&nbsp;
Cotality Chief Property Economist Kelvin Davidson says it reflects a mix of factors including short term loans, minimal or no break fees, and cash-back incentives.&nbsp;
He told Ryan Bridge it’s reasonably common to get 0.7-0.8% of the loan value as a cashback, up to certain caps, so it would make sense for people who are potentially under cashflow stress.&nbsp;
LISTEN ABOVE&nbsp;

A fresh and intelligent start to your day - catch the very latest international and domestic news developments, sport, entertainment and business on Early Edition with Ryan Bridge, on Newstalk ZB.

A fresh and intelligent start to your day - catch the very latest international and domestic news developments, sport, entertainment and business on Early Edition with Ryan Bridge, on Newstalk ZB.

Early Edition with Ryan Bridge

Kelvin Davidson: Cotality Chief Property Economist on the rising number of mortgage holders swapping loan providers

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/e438c475-6408-4000-94c7-b32901747bb5/transcript

The business sector will want to know how the Government will support them - as the Prime Minister prepares for his State of the Nation speech. 

Chris Luxon will give the address at the International Convention Centre in Auckland this afternoon - the first event to be held at the new centre. 

Newstalk ZB understands he will try to draw attention away from turbulent affairs overseas - and to the Government's successes back home. 

Auckland Business Chamber Chief Executive Simon Bridges told Andrew Dickens that he will question if economic relief is set to continue. 

He wants to know what fresh Government ideas are coming through which will keep business confidence up. 

LISTEN ABOVE

The business sector will want to know how the Government will support them - as the Prime Minister prepares for his State of the Nation speech.&nbsp;
Chris Luxon will give the address at the International Convention Centre in Auckland this afternoon - the first event to be held at the new centre.&nbsp;
Newstalk ZB understands he will try to draw attention away from turbulent affairs overseas - and to the Government's successes back home.&nbsp;
Auckland Business Chamber Chief Executive Simon Bridges told Andrew Dickens that he will question if economic relief is set to continue.&nbsp;
He wants to know what fresh Government ideas are coming through which will keep business confidence up.&nbsp;
LISTEN ABOVE

Simon Bridges: Auckland Business Chamber Chief Executive questions extent of economic relief ahead of State of the Nation speech

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/d052c40b-66a9-43ae-a14a-b3d601303539/transcript

Europe may be on the cusp of implementing a never-before-used law, to turn up the heat on the United States. 

President Donald Trump's announced increasing tariffs on eight countries starting next month, unless a deal allowing him to buy Greenland is reached. 

European leaders have condemned the decision, with France now set to urge the EU to enact its anti-coercion instrument,  if the tariffs go ahead.

Gavin Grey told Andrew Dickens that the international economic counter-measures will enhance their retaliation, within international law. 

He says no one quite knows what it means as it's never been needed until now, adding things are getting very serious. 

LISTEN ABOVE

Europe may be on the cusp of implementing a never-before-used law, to turn up the heat on the United States.&nbsp;
President Donald Trump's announced increasing tariffs on eight countries starting next month, unless a deal allowing him to buy Greenland is reached.&nbsp;
European leaders have condemned the decision, with France now set to urge the EU to enact its anti-coercion instrument, &nbsp;if the tariffs go ahead.
Gavin Grey told Andrew Dickens that the international economic counter-measures will enhance their retaliation, within international law.&nbsp;
He says no one quite knows what it means as it's never been needed until now, adding things are getting very serious.&nbsp;
LISTEN ABOVE

Gavin Grey: European correspondent discusses growing tension around Trump's demands for Greenland

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/f06a088d-43d6-4b4f-b502-b3d6012e257b/transcript

Pharmac is seeking clinical advice on whether weight loss medication should be funded in New Zealand. 

One in three people over the age of 15 are classified as obese and one in eight children aged between two and 14.

Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.

Auckland University Professor of Molecular Medicine Peter Shepherd told Andrew Dickens despite it being a short-term fix, it's like any other medicine. 

He says it's the same as heart disease or blood pressure medication - as soon as you go off them, they lose their effect as well.

Pharmac is seeking clinical advice on whether weight loss medication should be funded in New Zealand.&nbsp;
One in three people over the age of 15 are classified as obese and one in eight children aged between two and 14.
Pharmac received two applications to fund Wegovy or semaglutide - a GLP-1 receptor agonist for weight loss.
Auckland University Professor of Molecular Medicine Peter Shepherd told Andrew Dickens despite it being a short-term fix, it's like any other medicine.&nbsp;
He says it's the same as heart disease or blood pressure medication - as soon as you go off them, they lose their effect as well.

Peter Shepherd: Auckland University Professor of Molecular Medicine on Pharmac funding weight loss drugs

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/f0a4a0ea-66f9-43b0-b56b-b3d6011d6179/transcript

Kelvin Davidson: Cotality Chief Property Economist on the rising number of mortgage holders swapping loan providers

In 1 playlist(s)

Early Edition with Ryan Bridge

Social links

Follow podcast

Recent clips